Studies performed by Kurland, Sonkin, Title, and Morton reported the efficacy of synthetic T3 (liothyronine sodium
) in eliminating the symptoms of hypometabolism.
Other Sigmapharm releases include Liothyronine Sodium
Tablets, for hypothyroidism, which is the most stable Liothyronine product on the market with a shelf life of 36 months; Adefovir Dipivoxil Tablets, for hepatitis B, which is the first and only generic product equivalent to Hepsera Tablets; and Sodium Phenylbutyrate Powder, for urea cycle disorders, which is the first and only generic product equivalent to Buphenyl Powder.
Its ANDA for liothyronine sodium
tablets USP was approved in 5-, 25- and 50-mcg bases.
These include Midamor, 5 mg, in 100 counts, as well as the authorized generic Amiloride HCI tablets USP, 5 mg, in 100 counts; Liothyronine sodium
tablets USP, 5 mcg, 25 mcg and 50 mcg (all in 100 counts); Lorazepam oral concentrate USP, 2 mg/mL; and Moexipril HCI/HCTZ tablets, 7.5 mg/12.5 mg, 15 mg/12.5 mg and 15 mg/25 mg (all in 100 counts).
injection, 10 Triostat injection